Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies have shown that the adhE gene, which encodes a multifunctional protein with
ethanol dehydrogenase
activity, is under transcriptional regulation. The level of dehydrogenase activity in cells grown fermentatively is about 10-fold higher than that in cells grown aerobically. In these studies, we mapped the promoter to a region well upstream of the protein-coding region of adhE. Unexpectedly, in mutants lacking the endoribonuclease
RNase III
, no significant
ethanol dehydrogenase
activity was detected in cells grown anaerobically on rich (Luria-Bertani) medium supplemented with glucose, even though adhE mRNA levels were high. Indeed, like Delta adhE mutants, strains lacking
RNase III
failed to grow fermentatively on glucose but grew on the more oxidized carbon source glucuronate. Computer-generated secondary structures of the putative 5' untranslated region of adhE mRNA suggest that the ribosome binding site is occluded by intramolecular base pairing. It seems likely that cleavage of this secondary structure by
RNase III
is necessary for efficient translation initiation.
...
PMID:Translation of the adhE transcript to produce ethanol dehydrogenase requires RNase III cleavage in Escherichia coli. 876 68